Ed Silverman (Pharmalot / WSJ) $RTRX (and others)
A great investing quote, and how it relates to recent biotech IPOs
Brad Loncar (Loncar Blog)
Finding Risks, Not Answers, in Gene Tests
Denise Grady and Andrew Pollack (New York Times)
"Forced switch" maneuver spurs lawsuit against drug maker
Jonathan Lapook (CBS News)
FierceBiotech 2014 Fierce 15
"12th annual take on some of the most noteworthy private biotech upstarts making headway these days" - John Carroll, Editor
Biology: Three Known Unknowns
Katherine Bourzac (Scientific American)
"Even as cancer therapies improve, basic questions about drug resistance, tumour spread and the role of normal tissue remain unanswered"
Nutrition: Vitamins on trial
Melinda Wenner Moyer (Nature News)
"After decades of study, researchers still can't agree on whether nutritional supplements actually improve health"